-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics Presents Oral Clinical Update On (Z)-endoxifen At MDA Clinical & Scientific Conference

Benzinga·03/12/2026 12:12:45
Listen to the news

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other rare disease indications with significant unmet need, presented an oral clinical trial update on (Z)-endoxifen at the MDA Clinical & Scientific Conference on March 11, 2026, in Orlando, FL.